Screening services
Follow the links below to find trusted information about screening services.
Last reviewed: July 2016
Need more information?
These trusted information partners have more on this topic.
Found 565 results
BreastScreenNT bus - NT.GOV.AU
The BreastScreenNT bus gives free breast screening services to women in regional and remote communities.
Read more on NT Health website
Baby and child screening and assessment clinics - NT.GOV.AU
The Child Health Service runs health and development screening and assessments for your baby and child.
Read more on NT Health website
Perinatal mental health training
In response to the recognised need for free, accessible training for all primary/maternity health care professionals, beyond babyblues has developed a fully accredited, online training program.
Read more on beyondblue website
Our Results
We currently provide online or telephone screening assessments to about 350 new people each week. Since we launched the service in late 2012 we have had more than 30,000 Australians register to complete a MindSpot Screening Assessment.
Read more on MindSpot Clinic website
Welcome to Cancer Screening and Control Services | Cancer Screening and Control Services
Read more on Tasmanian Department of Health and Human Services website
Pregnancy screening and testing - NT.GOV.AU
Your first doctor visit, scheduled pregnancy check-ups, tests, ultrasounds and genetic screening.
Read more on NT Health website
Support for new parents - NT.GOV.AU
Support groups, useful websites, health services for new parents and general information for mothers-to-be
Read more on NT Health website
International Diagnostic Guidelines
In Australia there are currently no nationally recognised clinical guidelines for the screening and diagnosis of FASD. However, the Australian FASD Collaboration has developed a national diagnostic instrument for FASD. It is hoped that this will be tested in 2013-14. As part of this process clinical guidelines will be developed for its use. For more information about diagnosis in Australia go to What is FASD?
Read more on NOFASD - National Organisation for Fetal Alcohol Spectrum Disorder website
Important things to know
A MindSpot Online Screening Assessment will help you to understand your own symptoms better. A MindSpot Clinic Course will help you to learn to get control over your symptoms. However, we cannot guarantee that you will receive any benefits from a course.
Read more on MindSpot Clinic website
Pregnancy - Pregnancy Topics - Blood tests for your newborn baby - newborn screening test
All parents are offered the opportunity to have their baby screened for a number of rare disorders. This test is called the newborn screening. You might also hear it called the heel prick test. Before the test is done you will be given a pamphlet which tells you more about this test.
Read more on Women's and Children's Health Network website
Found 176 results
Screening and case finding instruments for depression | Cochrane
The use of depression screening or case finding instruments has little or no impact on the recognition, management or outcome of depression in primary care or the general hospital.
Read more on Cochrane (Australasian Centre) website
Vision screening of older drivers to prevent road traffic injuries and deaths | Cochrane
Good vision is critical for safe driving performance.Because vision declines with age, and the percentage of older adults in the population is increasing, it has become more important to consider the vision screening requirements for older adults when designing evidence-based traffic safety policy. Mandatory vision screening for the issue or renewal of a driver's licence helps to ensure that older drivers are fit to safely operate vehicles.To date, there has been no trial to demonstrate the impact of vision screening on the prevention of older driver-related crashes. However, given the importance of good vision for safe driving, vision testing remains a relevant issue for all licensed drivers.
Read more on Cochrane (Australasian Centre) website
Breast Screening
This pathway provides guidance on the screening imaging of adult female patients with an average risk of developing breast cancer.
Read more on Diagnostic Imaging Pathways website
Community screening for visual impairment in the elderly | Cochrane
Visual impairment is common among older people and is associated with falls and reduced quality of life. Visual problems in older people are often not reported to medical services. Screening has been recommended because vision could be improved by encouraging treatment in the majority of older people with impaired vision. The review found five studies in which vision was tested as part of a broader screening assessment. No improvement in vision was seen two to four years after screening compared to elderly people who were not screened. This may be due to the lack of a clear plan of intervention for visual problems found on screening. In another study, the risk of having visual impairment in either eye was similar with universal and targeted screening, three to five years after screening.
Read more on Cochrane (Australasian Centre) website
Screening for oesophageal cancer | Cochrane
Oesophageal cancer is a common cause of cancer related death in the world. The prognosis in the advanced stages is unfavourable, but the early oesophageal cancers are asymptomatic and curable, and usually go undetected until they have spread beyond the oesophageal wall. Endoscopy with iodine staining or cytologic examination are two common screening tests for early oesophageal cancer. These screening tests were started in the 1970s, but the true benefit is inconsistent and is uncertain due to lead-time bias, which is the amount of time by which the diagnosis is advanced by the screening procedure; and length-time bias, where screening is more likely to detect slow-growing disease rather than altering the person's duration of life. This review intended to determine the efficacy of the two screening tests for oesophageal cancer. We identified 3482 studies but none were RCTs of screening. Several non-comparative studies showed that the screening tests may increase the incidence of reported oesophageal cancer and improve the survival results after a screening test, but these results could indicate bias rather than a true causative effect. Therefore, there is a strong need for randomised controlled trials (RCTs), especially long-term RCTs, to determine the efficacy, cost-effectiveness, and any adverse effects of screening for oesophageal cancer.
Read more on Cochrane (Australasian Centre) website
First Trimester Screening
This pathway provides guidance on the screening of pregnant patients to detect fetal abnormalities in early pregnancy.
Read more on Diagnostic Imaging Pathways website
Screening for breast cancer with mammography | Cochrane
Screening with mammography uses X-ray imaging to find breast cancer before a lump can be felt. The goal is to treat cancer earlier, when a cure is more likely. The review includes seven trials that involved 600,000 women in the age range 39 to 74 years who were randomly assigned to receive screening mammograms or not. The studies which provided the most reliable information showed that screening did not reduce breast cancer mortality. Studies that were potentially more biased (less carefully done) found that screening reduced breast cancer mortality. However, screening will result in some women getting a cancer diagnosis even though their cancer would not have led to death or sickness. Currently, it is not possible to tell which women these are, and they are therefore likely to have breasts or lumps removed and to receive radiotherapy unnecessarily. If we assume that screening reduces breast cancer mortality by 15% after 13 years of follow-up and that overdiagnosis and overtreatment is at 30%, it means that for every 2000 women invited for screening throughout 10 years, one will avoid dying of breast cancer and 10 healthy women, who would not have been diagnosed if there had not been screening, will be treated unnecessarily. Furthermore, more than 200 women will experience important psychological distress including anxiety and uncertainty for years because of false positive findings.
Read more on Cochrane (Australasian Centre) website
Screening for nasopharyngeal cancer | Cochrane
Does screening individuals without symptoms using an Epstein-Barr virus blood test or nasopharyngoscopy (or both) reduce the mortality associated with nasopharyngeal cancer?
Read more on Cochrane (Australasian Centre) website
National Bowel Cancer Screening Program for health professionals
The National Bowel Cancer Screening Program currently offers free bowel cancer screening to eligible Australians turning 50, 55, 60, 65, 70 and 74 years of age.
Read more on Medicare website
Screening for testicular cancer | Cochrane
Testicular cancer commonly affects men aged between 20 and 35 years. It accounts up to 2% of cancers diagnosed in men, although the lifetime risk of mortality is less than 1%. Screening for testicular cancer is commonly performed by physician, who performs a physical examination, or self-examination by the patient. However, there is little evidence that documents the accuracy of such examinations. This review identified that no randomised controlled trials have been performed to evaluate the effectiveness of screening for testicular cancer. In the absence of high quality evidence, male patients with an increased risk of developing testicular cancer should be informed of the potential benefits and harms associated with screening.
Read more on Cochrane (Australasian Centre) website
